Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830466 · ClinicalTrials.gov registry record · Phase 1
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
A Phase 1 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT00830466 is a Phase 1 study that has completed, run by University of California, Irvine. The registered enrollment target is 22 participants.
The verdict
NCT00830466, a Phase 1 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The researchers want to collect data on safety and efficacy of combined pulsed dye laser and rapamycin to improve fading/blanching of port wine stain birthmarks as compared to pulsed dye laser alone, which is the current standard of care. This single center pilot and feasibility study will have a target enrollment of 40 port wine stain subjects at the Beckman Laser Institute and Medical Clinic, University of California, Irvine.
Interventions
- DRUG Laser and rapamycin versus laser alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2008-12 |
| Est. Completion | 2016-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00830466
The ClinicalTrials.gov registry entry for NCT00830466 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Laser and rapamycin versus laser alone is the first listed.
NCT00830466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00830466 about?
NCT00830466 is a clinical study titled "A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.". The researchers want to collect data on safety and efficacy of combined pulsed dye laser and rapamycin to improve fading/blanching of port wine stain birthmarks as compared to pulsed dye laser alone, which is the current standard of care. This single center pilot and feasibility study will have a t...
What is the current status of trial NCT00830466?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2008-12. Estimated completion is 2016-01.
What interventions are being tested in trial NCT00830466?
The interventions under investigation include: Laser and rapamycin versus laser alone (DRUG).
Who is sponsoring clinical trial NCT00830466?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.